Why Nutex Health Inc.’s (NUTX) Stock Is Down 10.14%

By Omar Beirat
April 28, 2025
Featured Tickers:

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Nutex Health Inc. before investing.

In this article, we go over a few key elements for understanding Nutex Health Inc.’s stock price such as:

  • Nutex Health Inc.’s current stock price and volume
  • Why Nutex Health Inc.’s stock price changed recently
  • Upgrades and downgrades for NUTX from analysts
  • NUTX’s stock price momentum as measured by its relative strength

About Nutex Health Inc. (NUTX)

Before we jump into Nutex Health Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Nutex Health Inc. operates as a physician-led, healthcare services, and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations through its Management Services Organization (MSO), Nutex provides management, administrative, and other support services to its affiliated hospitals and physician groups; and offers a cloud-based platform for healthcare organizations. The Real Estate segment owns and leases land and hospital buildings. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments that offer 24/7 care. In addition, the company provides healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; onsite inpatient pharmacies; emergency services; and in-patient services. The company was founded in 2011 and is headquartered in Houston, Texas.

Want to learn more about Nutex Health Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Nutex Health Inc..

Learn More About A+ Investor

Nutex Health Inc.’s Stock Price as of Market Close

As of April 28, 2025, 12:26 PM, CST, Nutex Health Inc.’s stock price was $111.018.

Nutex Health Inc. is down 10.14% from its previous closing price of $123.540.

During the last market session, Nutex Health Inc.’s stock traded between $105.420 and $121.770. Currently, there are approximately 5.22 million shares outstanding for Nutex Health Inc..

Nutex Health Inc.’s price-earnings (P/E) ratio is currently at 12.7, which is low compared to the Health Care Providers & Services industry median of 24.6. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Nutex Health Inc. Stock Price History

Nutex Health Inc.’s (NUTX) price is currently up 136.06% so far this month.

During the month of April, Nutex Health Inc.’s stock price has reached a high of $152.510 and a low of $64.600.

Over the last year, Nutex Health Inc. has hit prices as high as $152.510 and as low as $4.160. Year to date, Nutex Health Inc.’s stock is up 250.32%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Nutex Health Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 25, 2025, there were analysts who downgraded Nutex Health Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Nutex Health Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Nutex Health Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Nutex Health Inc.’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Nutex Health Inc. (NUTX) by visiting AAII Stock Evaluator.

Relative Price Strength of Nutex Health Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 25, 2025, Nutex Health Inc. has a weighted four-quarter relative price strength of 146.00%, which translates to a Momentum Score of 100 and is considered to be Very Strong.

Want to learn more about how Nutex Health Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Nutex Health Inc. Stock Price: Bottom Line

As of April 28, 2025, Nutex Health Inc.’s stock price is $111.018, which is down 10.14% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Nutex Health Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
High Relative Dividend
Yield Screen:
8.7% Compared to S&P 500
at only 6.9%

Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.